Financials
Financial year 2025
CONSORTIUM PHARMACEUTIQUE DE BELGIQUE from Ukkel, company number BE0874822610, closed financial year 2025 with a result of € 70,413 after tax. For that financial year CONSORTIUM PHARMACEUTIQUE DE BELGIQUE recorded a gross margin of € 381,555 and equity of € 340,056. Compared with financial year 2024, the result moved from € 69,162 to € 70,413. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 340,056
▲ 26% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 70,413
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 265,028
▲ 66% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 278,556.
People and assets in 2025
2.4
Average over the fiscal year, from the social balance sheet.
€ 230,448
▲ 6% vs 2024
€ 96,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,152
▲ 42% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 212,276
Loans from banks and other lenders, long and short.
€ 601,486
▲ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 121,835
▲ 76% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 413,339 | € 351,898 | € 363,685 | € 381,555 | ▲ 5% |
| Profit after taxes | € 83,014 | € 66,202 | € 69,162 | € 70,413 | ▲ 2% |
| Equity | € 168,328 | € 200,481 | € 269,643 | € 340,056 | ▲ 26% |
| Total debts | € 906,506 | € 858,391 | € 888,292 | € 1,012,115 | ▲ 14% |
| Cash | € 314,159 | € 136,520 | € 159,857 | € 265,028 | ▲ 66% |
| Land & buildings | € 138,559 | € 126,832 | € 115,104 | € 103,377 | ▼ 10% |
| Retained profit | € 106,828 | € 138,981 | € 208,143 | € 278,556 | ▲ 34% |
| Dividend | € 26,500 | € 34,050 | € 0 | € 0 | |
| Bank debt | € 212,519 | € 162,558 | € 212,576 | € 212,276 | |
| Balance sheet total | € 1,074,834 | € 1,058,872 | € 1,157,935 | € 1,352,170 | ▲ 17% |
| Employees (FTE) | 3.9 | 3.4 | 2.4 | 2.4 |
Key figures of CONSORTIUM PHARMACEUTIQUE DE BELGIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to CONSORTIUM PHARMACEUTIQUE DE BELGIQUE?
What happened at CONSORTIUM PHARMACEUTIQUE DE BELGIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 70,413 (▲ 2% vs 2024). filed late Source: NBB ↗
- Marie Décarpentrie became a director. NBB
- Caroline Decarpentrie became a director. NBB
- New establishment in Ukkel. KBO
- New establishment in Ukkel. KBO
- New establishment in Frasnes-lez-Anvaing. KBO
- Start of the company according to the CBE. KBO
In short
From € 83,014 profit in 2022 to € 70,413 profit in 2025.
Paid € 112,946 in corporate taxes since 2022.
Best year ever: 2022, with € 83,014 profit.
On average € 159,000 of value added per employee in 2025.
A new publication or filing at CONSORTIUM PHARMACEUTIQUE DE BELGIQUE? We notify you, reason included.
Follow CONSORTIUM PHARMACEUTIQUE DE BELGIQUEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of BEL MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
CONSORTIUM PHARMACEUTIQUE DE BELGIQUEBehind CONSORTIUM PHARMACEUTIQUE DE BELGIQUE are Marie Décarpentrie, Charles Ransart and Caroline Decarpentrie. The shares are held by BEL MANAGEMENT (45%).
Directors
According to the 2025 annual accounts
Marie Décarpentrie
Director
since 2024
Charles Ransart
Director
since 2024
Shareholders
45%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Neerstallesteenweg 485
1180 Ukkel
Rue Emile Deltenre(SS) 3
7912 Frasnes-lez-Anvaing
Active since 11 July 2005
Engelandstraat 366
1180 Ukkel
Active since 1 October 2012
Homborch 71
1180 Ukkel
Active since 17 July 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.822.610
- VAT number
- BE 0874.822.610
- Registered office
- Neerstallesteenweg 485, 1180 Ukkel
- Names & denominations
- CONSORTIUM PHARMACEUTIQUE DE BELGIQUE · COPHARBEL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 July 2005
- Peppol
- Active · Active since 19 Feb 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels